-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Editorial ||FREE PAPER||
(1748) Views (400) Full article downloads
Authors: Garry Walsh
Published Date May 2006
Volume 2006:2(3) Pages 227 - 228
DOI: http://dx.doi.org/10.2147/TCRM.S
Garry Walsh
Asthmatic and Allergic Inflammation Group, School of Medicine, University of Aberdeen, UK
The third issue of volume two of Therapeutics and Clinical Risk Management presents review articles and original research papers on a wide range of topics.
Readers of this article also read:
Prescribing errors and other problems reported by community pharmacists
Editorial ||FREE PAPER||
Alendronate sodium in the management of osteoporosis
Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain model
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Erratum - Intracellular heavy metal nanoparticle storage
Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision
A case of recurrent bloody tears
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
